Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
RPHM | US
-0.02
-1.33%
Healthcare
Biotechnology
30/06/2024
30/08/2024
1.48
1.47
1.58
1.47
Reneo Pharmaceuticals Inc. a clinical-stage pharmaceutical company focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. Its lead product candidate is REN001 a potent and selective agonist of the peroxisome proliferator-activated receptor delta that is in clinical development for genetic mitochondrial diseases comprising primary mitochondrial myopathies and long-chain fatty acid oxidation disorders. Reneo Pharmaceuticals Inc. was incorporated in 2014 and is headquartered in Irvine California.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
High Short percentage (> 15%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
57.8%1 month
53.2%3 months
41.3%6 months
44.2%-
-
0.65
0.01
0.01
0.16
-
-
-61.06M
49.47M
49.47M
-
-
-
-
-54.00
42.02
16.83
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.30
Range1M
0.38
Range3M
0.62
Rel. volume
0.08
Price X volume
11.19K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
HOOKIPA Pharma Inc | HOOK | Biotechnology | 5.23 | 51.75M | 0.38% | n/a | 0.00% |
BioLineRx Ltd | BLRX | Biotechnology | 0.6469 | 51.72M | 0.95% | n/a | 223.55% |
Zivo Bioscience Inc | ZIVO | Biotechnology | 14.94 | 50.29M | 32.21% | n/a | -2.22% |
Anebulo Pharmaceuticals Inc. Common Stock | ANEB | Biotechnology | 1.92 | 49.79M | 5.14% | n/a | 0.00% |
Rallybio Corporation Common Stock | RLYB | Biotechnology | 1.15 | 47.71M | -3.36% | n/a | 0.35% |
Fortress Biotech Inc | FBIO | Biotechnology | 2.03 | 46.31M | -0.98% | n/a | 494.61% |
LAVA Therapeutics BV | LVTX | Biotechnology | 1.75 | 46.02M | -4.37% | n/a | 14.37% |
Akari Therapeutics Plc | AKTX | Biotechnology | 3.83 | 45.78M | 0.52% | n/a | -27.01% |
CALC | CALC | Biotechnology | 4.17 | 44.83M | -3.02% | n/a | 0.00% |
Aadi Bioscience Inc | AADI | Biotechnology | 1.81 | 44.55M | 3.43% | n/a | 1.34% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 3.68 | 39.85M | -1.12% | n/a | 54.96% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 2.34 | 28.51M | 13.04% | n/a | 16.03% |
ILAG | ILAG | Building Products & Equipment | 1.25 | 22.57M | 6.84% | n/a | 5.48% |
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 0.6131 | 18.67M | -4.20% | n/a | 204.46% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2495 | 3.93M | 5.94% | n/a | 0.00% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.391 | 3.72M | -6.28% | n/a | 19.98% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.45 | 3.70M | 13.28% | n/a | 9.62% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.47 | 2.11M | -7.84% | n/a | 0.00% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 0.16 | 0.97 | Cheaper |
Ent. to Revenue | - | 3,681.29 | - |
PE Ratio | - | 39.83 | - |
Price to Book | 0.65 | 14.54 | Cheaper |
Dividend Yield | - | 2.19 | - |
Std. Deviation (3M) | 41.35 | 76.13 | Lower Risk |
Debt to Equity | 0.01 | -2.05 | Expensive |
Debt to Assets | 0.01 | 0.25 | Cheaper |
Market Cap | 49.47M | 4.04B | Emerging |